Intellia Therapeutics Inc. named Graeme Bell CFO, succeeding Sapna Srivastava, who will be moving to a senior advisory role within the company.
Bell previously served as CFO at Anacor Pharmaceuticals Inc.
Discover more about S&P Global’s offerings